Matt Rosenberg is a counsel in the Intellectual Property &Technology Transactions Group. His practice focuses on the IP and technology-related issues in complex and multi-jurisdictional transactional matters, including mergers and acquisitions, joint ventures and spinoffs. He also regularly represents clients on IP licensing and sales, technology development and AI governance-related matters. Matt advises clients in a wide range of industries, including artificial intelligence, software, semiconductors, blockchain, telecommunications, sports, healthcare, financial services and consumer brands.
Matt was recognized by Best Lawyers: Ones to Watch in America for Technology Law (2023–2025).
Matt’s recent experience includes advising:
- Amazon in its $10.8 billion acquisition of Globalstar
- Dana Incorporated in its approximately $2.7 billion sale of its off-highway business to Allison Transmission Holdings
- GSK in its $950 million all-cash acquisition of 35Pharma
- IonQ in its strategic agreement with the University of Chicago to establish the IonQ Center for Engineering and Science
- I-Pulse in a definitive agreement for a $250 million award administered by the U.S. Department of Commerce’s CHIPS Research and Development Office
- JPMorgan Chase in building its legal governance framework for AI-related technology
- Metsera in its $10 billion sale to Pfizer, following a series of competing bids for the company by Pfizer and Novo Nordisk
- Nebius Group in its approximately $643 million acquisition of Eigen AI
- SSW Partners in its $1.6 billion acquisition of businesses of Delivery Hero, in connection with Uber Technologies’s $14.8 billion acquisition of Delivery Hero
- Warby Parker in its partnership with Google to develop AI-powered glasses
